Literature DB >> 10796720

Interventions for chronic suppurative otitis media.

J Acuin1, A Smith, I Mackenzie.   

Abstract

BACKGROUND: Chronic suppurative otitis media (CSOM) is a serious bacterial infection of the middle ear that can follow untreated acute otitis media.
OBJECTIVES: To assess the effects of different treatments for CSOM. SEARCH STRATEGY: We searched Medline from 1966 to 1996 and a bibliographic collection of the Hearing Impairment Research Group in Liverpool, UK. We handsearched two otolaryngology journals and contacted members of an international hearing network. SELECTION CRITERIA: Randomized trials of any method of management for patients with eardrum perforation and persistent otorrhea. DATA COLLECTION AND ANALYSIS: Three reviewers independently assessed eligibility and trial quality. One reviewer extracted data. We contacted investigators for clarifications. MAIN
RESULTS: Twenty-four trials involving 1660 people were included. Clinical definitions and severity of CSOM varied, methodological quality was generally low and follow-up was short. Treatment with antibiotics or antiseptics accompanied by aural toilet was more effective in resolving otorrhea than no treatment (two trials, odds ratio 0.37, 95% confidence interval 0.24 to 0. 57) or aural toilet alone (six trials, odds ratio 0.31, 95% confidence interval 0.23 to 0.43). Topical treatment with antibiotics or antiseptics was more effective than systemic antibiotics (six trials, odds ratio 0.46, 95% confidence interval 0.30 to 0.69). Combining topical and systemic antibiotics was not more effective than topical antibiotics. Topical quinolones were more effective than non-quinolones (five trials, odds ratio 0.26, 95% confidence interval 0.16 to 0.41). No difference in the effectiveness of topical antibiotics and topical antiseptics was found (three studies, odds ratio 1.34, 95% confidence interval 0.64 to 2.81). Some topical antibiotic combinations may be more effective than others in resolving otorrhea. Rates of adverse drug events were low and equal between groups. REVIEWER'S
CONCLUSIONS: Treatment of CSOM with aural toilet and topical antibiotics, particularly quinolones, is effective in resolving otorrhea and eradicating bacteria from the middle ear. Longterm outcomes such as preventing recurrences, closure of tympanic perforation and hearing improvement need to be further evaluated.

Entities:  

Mesh:

Year:  2000        PMID: 10796720     DOI: 10.1002/14651858.CD000473

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

1.  Comparative Clinical Study of the Effectiveness of MEKRITEN in Patients with Chronic Suppurative Otitis.

Authors:  Abror Mukhitdinov; Nemat Olimov; Shirinkhan Olimova
Journal:  Turk J Pharm Sci       Date:  2018-07-17

Review 2.  A benefit-risk assessment of ofloxacin otic solution in ear infection.

Authors:  Talen K H Wai; Michael C F Tong
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

3.  Impact of Educational Program on the Management of Chronic Suppurative Otitis Media among Children.

Authors:  Yousseria Elsayed Yousef; Essam A Abo El-Magd; Osama M El-Asheer; Safaa Kotb
Journal:  Int J Otolaryngol       Date:  2015-02-22

4.  Efficacy of Empirical Therapy With Combined Ciprofloxacin Versus Topical Drops Alone in Patients With Tubotympanic Chronic Suppurative Otitis Media: A Randomized Double-Blind Controlled Trial.

Authors:  Maisam Abbas Onali; Syeda Beenish Bareeqa; Sadaf Zia; Syed Ijlal Ahmed; Asneha Owais; Ahmad Nawaz Ahmad
Journal:  Clin Med Insights Ear Nose Throat       Date:  2018-01-11

Review 5.  Acute and chronic otitis media.

Authors:  Peter S Morris; Amanda J Leach
Journal:  Pediatr Clin North Am       Date:  2009-12       Impact factor: 3.278

6.  Bacterial otitis media in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Tewodros Tesfa; Habtamu Mitiku; Mekonnen Sisay; Fitsum Weldegebreal; Zerihun Ataro; Birhanu Motbaynor; Dadi Marami; Zelalem Teklemariam
Journal:  BMC Infect Dis       Date:  2020-03-17       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.